[2] [11] The American Diabetes Association recommends specific GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk
Even among those that don't report significant clinical side effects, the financial burden of these drugs, as well as the injectable nature of the most popular versions (which much be administered via subcutaneous injection), are major deterrents for many patients
Women taking semaglutide who are also on hormonal birth control or HRT face compounded risk factors
Second, whether mTOR itself drives ferroptosis and governs Mller-cell function in DR has not been settled, and the molecular details of how the AMPK/mTOR axis steers their crosstalk are fragmentary
Injections bypass the digestive system entirely, and your body receives the full dose of Vitamin B12, leading to quicker results
Ive personally been microdosing GLP-1s for over six months , and the results have been impressivenot just in body composition, but in behavioral alignment with healthy lifestyle goals , even in environments traditionally filled with temptation (like European vacations)